These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 11212319)

  • 1. Beyond blood pressure: new roles for angiotensin II.
    Lucius R; Gallinat S; Busche S; Rosenstiel P; Unger T
    Cell Mol Life Sci; 1999 Dec; 56(11-12):1008-19. PubMed ID: 11212319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insights and perspectives on intrarenal renin-angiotensin system: focus on intracrine/intracellular angiotensin II.
    Zhuo JL; Li XC
    Peptides; 2011 Jul; 32(7):1551-65. PubMed ID: 21699940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II type 1 receptor induced signal-transduction pathways as new targets for pharmacological treatment of the renin-angiotensin system.
    Schorb W; Ertl G
    Basic Res Cardiol; 1996; 91 Suppl 2():91-6. PubMed ID: 8957551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptosis induction and inhibition of cellular proliferation by angiotensin II: possible implication and perspectives.
    Antus B; Mucsi I; Rosivall L
    Acta Physiol Hung; 2000; 87(1):5-24. PubMed ID: 11032044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II signal transduction pathways.
    Sayeski PP; Ali MS; Semeniuk DJ; Doan TN; Bernstein KE
    Regul Pept; 1998 Nov; 78(1-3):19-29. PubMed ID: 9879743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II receptor blockade: an innovative approach to cardiovascular pharmacotherapy.
    Eberhardt RT; Kevak RM; Kang PM; Frishman WH
    J Clin Pharmacol; 1993 Nov; 33(11):1023-38. PubMed ID: 8300885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II receptors-antagonists, molecular biology, and signal transduction.
    Jagadeesh G
    Indian J Exp Biol; 1998 Dec; 36(12):1171-94. PubMed ID: 10093499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptors and their classification: focus on angiotensin II and the AT2 receptor.
    Csikós T; Chung O; Unger T
    J Hum Hypertens; 1998 May; 12(5):311-8. PubMed ID: 9655652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation and function of extrarenal angiotensin receptors.
    Wang DH; Elijovich F
    Cell Biochem Biophys; 1999; 31(1):1-17. PubMed ID: 10505665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into the functions of type 1 (AT1) angiotensin II receptors provided by gene targeting.
    Audoly LP; Oliverio MI; Coffman TM
    Trends Endocrinol Metab; 2000 Sep; 11(7):263-9. PubMed ID: 10920382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of renal glomerular angiotensin II receptors by ace inhibition and AT1 receptor antagonism.
    Haddad G; Amiri F; Garcia R
    Regul Pept; 1997 Jan; 68(2):111-7. PubMed ID: 9110382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II type 1 receptor-modulated signaling pathways in neurons.
    Richards EM; Raizada MK; Gelband CH; Sumners C
    Mol Neurobiol; 1999 Feb; 19(1):25-41. PubMed ID: 10321970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A local pancreatic renin-angiotensin system: endocrine and exocrine roles.
    Leung PS; Chappell MC
    Int J Biochem Cell Biol; 2003 Jun; 35(6):838-46. PubMed ID: 12676170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin AT2 receptor ligands: do they have potential as future treatments for neurological disease?
    Rosenstiel P; Gallinat S; Arlt A; Unger T; Sievers J; Lucius R
    CNS Drugs; 2002; 16(3):145-53. PubMed ID: 11888335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial angiotensin receptors and cardioprotective pathways.
    Escobales N; Nuñez RE; Javadov S
    Am J Physiol Heart Circ Physiol; 2019 Jun; 316(6):H1426-H1438. PubMed ID: 30978131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the renin-angiotensin system in cardiac hypertrophy.
    Yamazaki T; Komuro I; Yazaki Y
    Am J Cardiol; 1999 Jun; 83(12A):53H-57H. PubMed ID: 10750588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The renin-angiotensin system and experimental heart failure.
    Wollert KC; Drexler H
    Cardiovasc Res; 1999 Sep; 43(4):838-49. PubMed ID: 10615411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II type 2 receptor agonists: where should they be applied?
    Verdonk K; Danser AH; van Esch JH
    Expert Opin Investig Drugs; 2012 Apr; 21(4):501-13. PubMed ID: 22348403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of angiotensin II receptors (binding and mRNA) in the rat thyroid gland.
    Montiel M; Jiménez E
    J Mol Endocrinol; 1998 Jun; 20(3):299-304. PubMed ID: 9687152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotection with angiotensin receptor antagonists: a review of the evidence and potential mechanisms.
    Wilms H; Rosenstiel P; Unger T; Deuschl G; Lucius R
    Am J Cardiovasc Drugs; 2005; 5(4):245-53. PubMed ID: 15984907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.